Unitedhealth Group Inc header image

Unitedhealth Group Inc

UNH

Equity

ISIN null / Valor 1078451

New York Stock Exchange, Inc (2026-04-24)
USD 354.92+0.10%

Unitedhealth Group Inc
UMushroom community rating:

star star star star star
3.51 68 votes No rating yet
NegativeNeutralPositive

About company

UnitedHealth Group Inc. is a diversified health care company, operating through its two main subsidiaries, Optum and UnitedHealthcare, to foster a modern, efficient health system. Optum focuses on improving health care delivery through technology and data, providing tools and support to enhance the health of individuals and communities. UnitedHealthcare, on the other hand, offers a comprehensive range of health benefits, including affordable coverage and access to quality care, aimed at simplifying the health care experience for consumers. UnitedHealth Group is committed to serving the health care needs of over 152 million people worldwide, promoting a value-based care system that emphasizes compassionate and equitable treatment. The company's efforts are geared towards making high-quality care both affordable and accessible, leveraging cross-sector collaboration and technological innovation to meet consumer needs and improve the overall health care landscape.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-16.3%1Y
-27.4%3Y
-11.3%5Y

Performance

54.1%1Y
37.6%3Y
32.3%5Y

Volatility

Market cap

322152 M

Market cap (USD)

Daily traded volume (Shares)

8,554,577

Daily traded volume (Shares)

1 day high/low

509.71 / 500.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.51

68 votes
Performance:
starstarstarstarstar
3.28
Innovation:
starstarstarstarstar
3.18
Society:
starstarstarstarstar
3.43
Nature:
starstarstarstarstar
3.31
Aleenah Moghal
United Kingdom, 21 Feb 2026
star star star star star
undervalued, in the long term this will generate impressive returns, UNH is a premier company in the managed healthcare sector. The recent, steep decline caused by regulatory fears (Medicare Advantage) has improved its long term valuation, but in short term volatility is expected to continue.
Harry Root
United Kingdom, 21 Feb 2026
star star star star star
Undervalued in recent times
George Williams
United Kingdom, 20 Feb 2026
star star star star star
High Quality Undervalued

EQUITIES OF THE SAME SECTOR

Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.10%USD 31.57
Addus HomeCare Corp
Addus HomeCare Corp Addus HomeCare Corp Valor: 10385048
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.32%USD 95.71
Sareum Holdings PLC
Sareum Holdings PLC Sareum Holdings PLC Valor: 116566624
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.38%GBP 0.20
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.85%USD 22.08
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%USD 27.38
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.99%USD 22.42
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.10%CHF 84.52
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.74%USD 24.10
Viatris Inc
Viatris Inc Viatris Inc Valor: 58198423
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%USD 14.59
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%CHF 281.40